These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 454939)

  • 1. Effects of spiperone on feeding parameters in the rat and interactions with (+)-amphetamine, mazindol or (+/-)-fenfluramine [proceedings].
    Cooper SJ; Sweeney KF
    Br J Pharmacol; 1979 May; 66(1):147P-148P. PubMed ID: 454939
    [No Abstract]   [Full Text] [Related]  

  • 2. Feeding parameters in the rat: interactions of chlordiazepoxide with (+)-amphetamine or fenfluramine [proceedings].
    Cooper SJ; Francis RL
    Br J Pharmacol; 1978 Nov; 64(3):378P-379P. PubMed ID: 719237
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat.
    Samanin R; Bendotti C; Bernasconi S; Borroni E; Garattini S
    Eur J Pharmacol; 1977 May; 43(2):117-24. PubMed ID: 872869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mazindol on brain dopamine turnover in spiperone-treated rats.
    Fuller RW; Snoddy HD
    J Neural Transm; 1979; 44(1-2):13-9. PubMed ID: 438800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food-intake and locomotor activity: effects of mazindol and spiperone [proceedings].
    Cooper SJ; Sweeney KF
    Br J Pharmacol; 1978 Jun; 63(2):412P-413P. PubMed ID: 667485
    [No Abstract]   [Full Text] [Related]  

  • 6. Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes.
    Carruba MO; Picotti GB; Zambotti F; Mantegazza P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):1-5. PubMed ID: 882144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mazindol, fenfluramine and chlorimipramine on the 5-hydroxytryptamine uptake and storage mechanisms in rat brain: similarities and differences.
    Carruba MO; Picotti GB; Zambotti F; Mantegazza P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Nov; 300(3):227-32. PubMed ID: 600310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anorexic and behavioural effects of a new imidazo-isoindole derivative (mazindol) in comparison with d-amphetamine in the rat.
    Babbini M; Gaiardi M; Bartoletti M
    Pharmacology; 1977; 15(1):46-56. PubMed ID: 557207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anorectic action of mazindol.
    Sweeney KF
    Ir J Med Sci; 1978 Aug; 147 Suppl 1():66-70. PubMed ID: 689855
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of mazindol on feeding behaviour and on noradrenergic function of various parts of the rat brain.
    Halmy L; Nyakas C; Walter J
    Acta Physiol Acad Sci Hung; 1982; 59(4):341-7. PubMed ID: 7170986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive effect of (plus or minus)-fenfluramine and (+)-amphetamine on feeding in rats.
    Leshem MB; Blundell JE
    J Pharm Pharmacol; 1974 Nov; 26(11):905-6. PubMed ID: 4156565
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance and cross tolerance to the anorexigenic effect of appetite suppressants in rats.
    Opitz K
    Int J Obes; 1978; 2(1):59-68. PubMed ID: 711356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anorectic agents in rats bearing the Walker-256 tumor.
    Maickel RP; Johnson K; Kinney DR
    Res Commun Chem Pathol Pharmacol; 1987 Dec; 58(3):421-4. PubMed ID: 3438577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feeding parameters with two food textures after chlordiazepoxide administration, alone or in combination with d-amphetamine or fenfluramine.
    Cooper SJ; Francis RL
    Psychopharmacology (Berl); 1979 Apr; 62(3):253-9. PubMed ID: 111292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mazindol anorexia is mediated by activation of dopaminergic mechanisms.
    Kruk ZL; Zarrindast MR
    Br J Pharmacol; 1976 Nov; 58(3):367-72. PubMed ID: 990591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of depletion of brain dopamine by 6-hydroxydopamine on tolerance to the anorexic effect of d-amphetamine and fenfluramine in rats.
    Heffner TG; Seiden LS
    J Pharmacol Exp Ther; 1979 Jan; 208(1):134-43. PubMed ID: 759608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of stimulation by high amphetamine doses following a low dose of spiperone.
    Baez LA; Kerns RD; Smith P
    Eur J Pharmacol; 1977 Jan; 41(1):77-9. PubMed ID: 832667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mazindol, d-amphetamine and diethylpropion on purine nucleotide binding to brown adipose tissue.
    Lupien JR; Bray GA
    Pharmacol Biochem Behav; 1986 Oct; 25(4):733-8. PubMed ID: 3786335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished amphetamine anorexia and enhanced fenfluramine anorexia after midbrain 6-hydroxydopamine.
    Ahlskog JE; Randall PK; Hernandez L; Hoebel BG
    Psychopharmacology (Berl); 1984; 82(1-2):118-21. PubMed ID: 6420820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mazindol and d-fenfluramine of 5-hydroxytryptamine uptake, storage and metabolism in blood platelets.
    Picotti GB; Carruba MO; Zambotti F; Mantegazza P
    Eur J Pharmacol; 1977 Apr; 42(3):217-24. PubMed ID: 856607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.